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Abstract 31 
Listeria monocytogenes (Lm) pathogenesis depends on its ability to escape from the 32 
phagosome of the host cells via the action of the pore-forming toxin listeriolysin O (LLO). 33 
Expression of the LLO-encoding gene (hly) requires the transcriptional activator PrfA, and 34 
both hly and prfA genes are essential for Lm virulence. Here we used the hemolytic activity of 35 
LLO as a phenotypic marker to screen for spontaneous virulence-attenuating mutations in Lm. 36 
Sixty (0.1%) non-hemolytic isolates were identified among a collection of 57,820 confirmed 37 
Lm strains isolated from a variety of sources. In most cases (56/60), the non-hemolytic 38 
phenotype resulted from nonsense, missense or frameshift mutations in prfA. Five strains 39 
carried hly mutations leading to a single amino acid substitution (G299V) or a premature stop 40 
codon causing strong virulence attenuation in mice. In one strain, both hly and gshF 41 
(encoding a glutathione synthase required for full PrfA activity) were missing due to genomic 42 
rearrangements likely caused by a transposable element. The PrfA/LLO loss-of-function 43 
mutants belonged to phylogenetically diverse clades of Lm and most were identified among 44 
non-clinical strains (57/60). In line with the extremely low frequency of loss of virulence 45 
mutations, we show that prfA and hly are under purifying selection. Although occurring at a 46 
low frequency, PrfA–/LLO– mutational events in Lm lead to niche restriction and open an 47 
evolutionary path for obligate saprophytism in this facultative intracellular pathogen. 48 
 49 
Importance 50 
The hemolytic phenotype of Lm is a key identification criterion in food and clinical 51 
microbiology. Here we characterized 60 non-hemolytic Lm strains, identified by screening a 52 
vast collection of natural Lm isolates collected in the context of epidemiological surveillance 53 
of listeriosis. Phenotypic and genomic analyses demonstrated that the absence of hemolysis 54 
was due to loss-of-function mutations in prfA or hly, leading to strong virulence attenuation in 55 
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mice. We also identified the first natural Lm strain which spontaneously lost the gshF gene, 56 
required for the PrfA-dependent transcriptional activation of hly and other virulence genes. 57 
Previous phylogenomic studies have indicated that some non-pathogenic Listeria species 58 
derive from pathogenic ones, and the virulence-attenuating mutations characterized in this 59 
study illustrate the possible early events that could have determined their emergence and 60 
evolution. 61 
 62 
Introduction 63 
Listeria monocytogenes (Lm) is a foodborne pathogen that can cause a severe invasive disease 64 
in people and animals, called listeriosis. As a facultative intracellular bacterium, Lm has 65 
evolved a range of virulence determinants allowing intracellular survival (1, 2). One key 66 
virulence factor is listeriolysin O (LLO), a pore-forming toxin responsible for the 67 
characteristic ß-hemolytic phenotype of Lm that allows the bacterium to escape from the 68 
phagosome of host cells and replicate intracellularly (3, 4). LLO is encoded by hly, located in 69 
the Listeria Pathogenicity Island 1 (LIPI-1) (5). Expression of the genes within this central 70 
pathogenicity locus, including hly, is under the control of the transcriptional activator PrfA, 71 
the master regulator of Lm virulence genes (6, 7). 72 
The hemolytic activity conferred by LLO is considered a cardinal marker for Lm detection 73 
and/or identification in clinical and food microbiology. Lm is divided into four phylogenetic 74 
lineages (8-10), 13 serotypes (11) that can be approximated by PCR serogrouping (12), and 75 
more than 100 clonal complexes (CCs, as defined by multilocus sequence typing (MLST)) 76 
(13), which are unevenly virulent (14). Weakly or non-hemolytic Lm strains have been 77 
reported (15-19), but the frequency and phylogenetic diversity of the strains displaying an 78 
altered hemolysis phenotype is unknown, as well as their underlying genetic and 79 
microbiological features.  80 
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This study aimed at (i) estimating the frequency of naturally-occurring non-hemolytic Lm 81 
isolates and their distribution among Lm lineages and MLST clonal complexes, (ii) 82 
understanding the molecular bases of the non-hemolytic phenotype and (iii) assessing its 83 
impact on virulence. By using phenotypic and genomic approaches, mutagenesis and in vivo 84 
assays, we show that mutations leading to loss of hemolytic activity in Lm, although rare, 85 
affect a wide range of clonal complexes of the major lineages I and II and lead to a decreased 86 
virulence. 87 
 88 
Results 89 
Identification and characterization of non-hemolytic Lm strains 90 
We examined the prevalence of non-hemolytic Lm strains among the 57,820 Lm isolates 91 
collected between 1987 and 2008 at the French National Reference Centre for Listeria 92 
(NRCL) and the WHO Collaborating Centre for Listeria (WHOCCL). Sixty Lm isolates 93 
(0.1%) were identified as non-hemolytic on horse blood agar plates. These were isolated from 94 
food (n = 33), food production environments (n = 2), non-human unknown sources (n = 22) 95 
and human clinical cases (n = 3). Phenotypic characterization using the API Listeria system 96 
confirmed all 60 non-hemolytic isolates as Lm. These belonged to lineages I (n = 23, 38.3%) 97 
and II (n = 37, 61.7%) and were grouped within serogroups IIa (n = 36), IVb (n = 13), IIb (n = 98 
10) and IIc (n = 1) (Table S1). MLST showed that the 60 non-hemolytic isolates belonged to 99 
15 different clonal complexes, including the “hypovirulent” CC9 (n = 1), CC121 (n = 3), 100 
CC31 (n = 20) and ST13 (n = 3) (14, 20), but also the “hypervirulent” CC1 (n = 3), CC2 (n = 101 
7), CC4 (n = 1) and CC6 (n = 1) (14) (Table S1 and Fig. 1). Core genome MLST (cgMLST) 102 
typing identified 39 different cgMLST types (CTs) (21). Nine CTs comprised more than one 103 
strain, suggesting a possible epidemiological link between them (21) (Table S1). In 104 
particular, among the twenty non-hemolytic CC31 strains, ten belonged to CT878 and two 105 
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belonged to CT2659, suggesting that the overrepresentation of CC31 could be in part due to 106 
multiple sampling of the same source in the context of an epidemiological investigation. 107 
These results show that non-hemolytic strains are phylogenetically very diverse and that the 108 
loss of hemolytic activity is caused by independent events across the Lm population. 109 
To investigate the impact of the loss of hemolytic activity in Lm fitness, we analyzed the 110 
growth of all non-hemolytic strains in BHI at 22°C and 37°C, using EGDe as control (Fig. 111 
S1). At 22°C, in a large majority of cases, the growth of non-hemolytic strains was within the 112 
same range as EGDe, as revealed by the areas under their growth curves (AUCs). On the 113 
contrary, at 37°C, temperature in which prfA is known to be maximally expressed (22), most 114 
of the non-hemolytic strains showed lower growth (lower AUCs) than EGDe. Some of the 115 
non-hemolytic strains showed particularly decreased fitness in one or both temperature: CLIP 116 
2000/86467 (PrfAT170*, at 22°C), CLIP 1998/75799 (PrfAI51*-LLON261*, at 37°C) and, at both 117 
temperatures, strains CLIP 1998/76801 (Δhly-ΔgshF), CLIP 1996/70991 (PrfAQ21*), CLIP 118 
1994/58618 (PrfAA129P) and CLIP 1996/71614 (PrfAY207*) (Fig. S1). 119 
 120 
Molecular basis of non-hemolytic phenotype – PrfA variants and activity 121 
The central regulator of Listeria virulence, PrfA, is required for the expression of a set of key 122 
virulence determinants, known as the PrfA regulon, including the hly gene (6, 7, 23). 123 
Consequently, mutations altering the function of either PrfA or LLO could lead to a non-124 
hemolytic phenotype. Sequence analyzes identified frameshifts and missense and nonsense 125 
mutations in prfA in 56 non-hemolytic strains, leading to amino-acid substitutions or protein 126 
truncations in PrfA (Fig. 1; Table S1). Phenotypic analysis in PrfA-activating and non-127 
activating conditions using the PrfA-dependent virulence factors PlcB (phospholipase C) and 128 
Hpt as reporters (see Materials and Methods) (24) confirmed the complete loss of function of 129 
the central virulence gene regulator in all of these strains (Fig. 1; Fig. S2). 130 
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Forty-three out of the 56 PrfA- strains, distributed in lineages I and II, expressed a truncated 131 
PrfA at 14 distinct positions distributed along the entire PrfA protein (Table S1). All analyzed 132 
strains of CC59 and CC31 exhibited a truncation at positions 59 and 185, respectively, 133 
suggesting a common ancestor for each of these groups of strains. Seven PrfA- strains 134 
presented a single amino-acid substitution in PrfA as compared to the reference strain EGDe 135 
(accession number: NC_003210). Among them, one occurred in the β-roll region of PrfA 136 
(G72D, strain CLIP 1997/75561, CC9). Mutations located in this region are known to affect 137 
PrfA activation or the ability of PrfA to form a stable complex with the RNA polymerase and 138 
initiate transcription of the target virulence genes (25-27). One PrfA- mutation occurred in the 139 
DNA-binding helix-turn-helix (HTH) domain of PrfA (G175C, strain CLIP 2006/01642, 140 
CC6) and two others in its C-terminal part (K220T, strains CLIP 1994/60344, CLIP 141 
2000/80770 and CLIP 2001/87255, all ST13; and L221F, strain CLIP 1994/56373, CC1). 142 
These regions are known to be important for the binding of PrfA to PrfA-binding sites of 143 
target DNAs (25, 26). In addition, the A129P substitution, located between the β-roll and the 144 
hinge αD regions, occurred in a CC224 strain (CLIP 1994/58618). Finally, six of the PrfA- 145 
strains, all belonging to CC155, showed a reversion of the prfA stop codon due to the 146 
insertion of 5 nucleotides at position 712 in the prfA sequence, leading to a longer PrfA 147 
protein (238 amino acids in EGDe vs 293 amino acids in the CC155 strains of this study). 148 
One of the four non-hemolytic mutants (CC1 strain CLIP 1998/76801) exhibited a wild-type 149 
(WT) PrfA sequence as compared to EGDe, but showed a PrfA- phenotype. This observation 150 
suggested that a mechanism interfering upstream of PrfA function was affected. Glutathione, 151 
synthetized by Lm through the glutathione synthase encoded by gshF (lmo2770), is critical for 152 
PrfA activation (28). Interestingly, although it is part of the Lm core genome (14, 21), gshF 153 
was absent in the genome of the CLIP 1998/76801 strain (Fig. 1) (see below), which could 154 
explain the absence of PrfA activity in this strain. 155 
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 156 
Analysis of spontaneous LLO mutants 157 
Analysis of hly sequences in the 60 non-hemolytic strains identified multiple mutations 158 
leading to amino acid substitutions in LLO (Table S1). Several substitutions (N31H, S35L, 159 
V438I and K523S) were identified in at least 48 hemolytic Lm strains of our database 160 
(~ 4,100 genomes), suggesting that they do not cause LLO loss of function. However, a 161 
S250N substitution was only found in three non-hemolytic strains of this study (CLIP 162 
2008/01432, 2008/01433 and 2008/01435, all CC77) and could therefore result in LLO loss 163 
of function. Since these strains also expressed a truncated and non-active PrfA, which is 164 
sufficient to explain the non-hemolytic phenotype of these strains, we did not pursue this 165 
further. 166 
Two out of the three non-hemolytic strains showing a WT PrfA sequence and a PrfA+ 167 
phenotype (CC121 strains CLIP 2007/01406 and CLIP 2007/01014) exhibited a single amino 168 
acid substitution in LLO (hlyG299V or LLOG299V), which was not present in any of the other 169 
strains. The third strain (CC2, CLIP 1989/13656) harbored a premature stop codon at position 170 
484 in LLO (hlyC484* or LLOC484*). The absence of any other specific feature in these three 171 
strains that could be linked to the loss of hemolytic activity suggested that the G299V 172 
mutation and the truncation at position 484 in LLO could be the cause of the loss of hemolytic 173 
activity in these strains. In addition, two CC7 strains expressing a truncated PrfA (CLIP 174 
1998/75799 and CLIP 1989/14490) also showed a premature stop codon in LLO at position 175 
261 (hlyN261*) due to the insertion of one nucleotide.  176 
In the CLIP 1998/76801 strain mentioned above, hly could not be detected by PCR and the 177 
hly region could not be assembled from Illumina reads. In order to resolve this region, we 178 
sequenced this strain using the single molecule, real-time (SMRT) sequencing technology 179 
(Pacific Biosciences, California, USA). The CLIP 1998/76801 complete genome (CC1, 180 
 9 
2.84 Mb) was compared to the closely related F2365 complete genome (CC1, NCBI 181 
accession number NC_002973) as reference. This showed that the LIPI-1 region had 182 
undergone an inversion of more than 40 kb (Fig. 2A). This large rearrangement splitted LIPI-183 
1 into two parts with concomitant loss of hly and partial truncation of the 5’ region of the 184 
adjacent mpl gene. Six ORFs were inserted upstream of mpl in CLIP 1998/76801 as compared 185 
to F2365, comprising genes encoding a transposition protein (tnsB) and a DNA invertase 186 
(hin), which are likely the cause of the rearrangement, as well as cadmium resistance genes 187 
(cadA and cadC) (Fig. 2A). 188 
We confirmed that gshF is absent in CLIP 1998/76801, together with 12 other upstream and 189 
downstream genes related to sugar metabolism (Fig. 2B). These genes were replaced by 11 190 
ORFs encoding a transposition protein (tnsB), a DNA invertase (hin) and cadmium resistance 191 
genes (cadA and cadC) similar to those inserted in the LIPI-1 region. In total, eight similar 192 
copies of this transposable element were found in the CLIP 1998/76801 genome, as well as 193 
many other large rearrangements and deletions (Fig. 2C). Similar transposable elements were 194 
detected in one L. ivanovii strain in NCBI database (accession number KR780025.1; 99% 195 
nucleotide identity, full length) and in 128 Lm strains (> 99.87% nucleotide similarity, full 196 
length) out of the 4,091 genome sequences available at the NRCL at the time of the study. 197 
These strains comprised 14.1% of all the CC1 strains (90/638, representing two distinct 198 
monophyletic groups within the phylogeny of CC1, data not shown) and all the CC59 strains 199 
(n = 38). No significant link of this element with food or clinical origins was found within 200 
CC1. 201 
 202 
Assessment of hly and prfA transcription 203 
In order to test the effect of the identified mutations on hly and prfA transcription, qRT-PCRs 204 
were performed for a representative set of non-hemolytic strains (one strain per type of loss-205 
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of-hemolysis mutation, Table S1). All non-hemolytic strains showed prfA transcription levels 206 
equivalent to or higher than EGDe, except for strains CLIP 1998/75799 (PrfAI51*-LLON261* 207 
mutations) and CLIP 1998/77604 (PrfAT76* mutation), which showed no amplification, likely 208 
due to poor primer annealing (8 mismatches with the prfA-R primer) (Fig. S3). As expected, 209 
strains with altered PrfA (aa substitution or truncation) showed no or extremely reduced hly 210 
transcription levels. These results show that for these strains the loss of hemolytic activity is 211 
due to prfA post-transcriptional events leading to the absence of PrfA activity. In the strain 212 
CLIP 2007/01406 (LLOG299V), hly was transcribed at a similar level than in EGDe, whereas in 213 
CLIP 1989/13656 (LLOC484*), hly transcription was weaker. 214 
 215 
In vitro characterization of the hlyG299V and hlyC484* mutations 216 
In order to characterize the functional impact of the G299V substitution (CLIP 2007/01406 217 
and CLIP 2007/01014) and of the truncation at position 484 in LLO (CLIP 1989/13656), we 218 
introduced a plasmid containing either a wild type hly gene (hlyWT) or a mutated version of 219 
this gene (hlyG299V or hlyC484*, encoding LLOG299V and LLOC484*, respectively) in a EGDΔhly 220 
strain. While EGDΔhly:pPL2-hlyWT was hemolytic, EGDΔhly:pPL2-hlyG299V or 221 
EGDΔhly:pPL2-hlyC484* remained non-hemolytic, as assessed on Columbia horse blood agar-222 
plates. These results demonstrate that the hlyG299V and hlyC484* mutations are responsible for 223 
the absence of hemolytic activity in the strains CLIP 2007/01406, CLIP 2007/01014 and 224 
CLIP 1989/13656. 225 
Western blot analyses of culture supernatants detected lower amounts of LLO produced by 226 
EGDΔhly:pPL2-hlyG299V and EGDΔhly:pPL2-hlyC484* bacteria as compared to the WT EGD 227 
and EGDΔhly:pPL2-hlyWT strains (Fig. 3A). qRT-PCR analyses showed that hly transcription 228 
level in both EGDΔhly:pPL2-hlyG299V and EGDΔhly:pPL2-hlyC484* strains is comparable to 229 
that observed in EGDΔhly:pPL2-hlyWT, although slightly weaker for EGDΔhly:pPL2-hlyC484* 230 
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(Fig. 3B). Furthermore, the EGDΔhly:pPL2-hlyC484* mutant produced a shorter LLO protein 231 
as compared to strains harboring the hlyWT, confirming that the premature stop codon 232 
identified in hly in the CLIP 1989/13656 strain leads to the production of a truncated LLO. 233 
The hlyN261* mutation (Fig. 1; Table S1) was not tested in vitro as this premature stop codon 234 
is upstream of the hlyC484* mutation, leading to an even shorter LLO. 235 
 236 
Virulence of hlyG299V and hlyC484* mutants 237 
We finally assessed the virulence of the EGDΔhly:pPL2-hlyG299V and EGDΔhly:pPL2-hlyC484* 238 
complemented strains relative to that of the EGDΔhly:pPL2-hlyWT and EGDΔhly:pPL2 strains 239 
upon intravenous injection in mice. EGDΔhly:pPL2-hlyG299V and EGDΔhly:pPL2-hlyC484* 240 
strains were four order of magnitude less abundant than the EGDΔhly:pPL2-hlyWT strain in 241 
the liver and the spleen (Fig. 3C). This demonstrates that the virulence of Lm expressing 242 
either LLOG299V or LLOC484* is strongly attenuated in vivo.  243 
 244 
Discussion 245 
Virulence gene polymorphisms leading to Lm attenuation have been previously described and 246 
have been associated with strains of lower pathogenic potential. The best characterized are 247 
those affecting the invasion-associated inlA gene, found in a large proportion (>25-30%) of 248 
lineage II food isolates but extremely rare among lineage I strains, more frequently associated 249 
with clinical cases (13, 21, 29, 30). Mutations leading to more radical Lm virulence 250 
attenuation have also been characterized, particularly those affecting the prfA gene (31-33), 251 
but their frequency and distribution across the Lm population remained undetermined. Here 252 
we examined the occurrence of “loss-of-virulence” mutations in Lm by screening a wide and 253 
diverse panel of strains for hemolytic activity. Our data shows that non-hemolytic Lm mutants 254 
occur at low frequency (0.1%) and are phylogenetically diverse, including strains belonging 255 
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to hypovirulent and hypervirulent clonal complexes (14). This indicates that the underlying 256 
mutational events are not linked to the genetic background of the strains. 257 
Lm hemolytic phenotype depends on two essential virulence determinants, the central 258 
virulence regulator PrfA and LLO, encoded by prfA and hly, respectively. Indeed, all non-259 
hemolytic strains identified in this study carried mutations in either of these genes. The large 260 
majority of non-hemolytic strains (56/57,820; 95%) carried prfA mutations (frameshifts, 261 
missense or nonsense nucleotide changes, or reversion of the stop codon into a glutamine 262 
codon). Although no PrfA activity could be detected and hly was not transcribed in these 263 
strains, prfA was transcribed at similar levels to EGDe. This suggests that the loss of PrfA 264 
activity in these strains likely results from PrfA misfolding, instability and/or inactivating 265 
amino-acid substitution. Some inactivating amino acid substitutions in PrfA occurred in the β-266 
roll, HTH motif or C-terminal domain, in line with the critical role of these regions in PrfA 267 
activity (25-27, 31). As PrfA is the major transcriptional regulator of Lm virulence genes and 268 
is essential for its pathogenicity (23, 34), the virulence of  PrfA- strains are expected to be 269 
highly attenuated as previously described (31-33). The first Lm strain naturally producing a C-270 
terminally-extended PrfA polypeptide (55 residues longer) was identified in this study and 271 
showed no PrfA activity and no hly transcription. 272 
Comparatively to PrfA, non-hemolytic hly mutants with affected LLO activity were less 273 
frequent (5/57,820; 0.01%) in our study. Our analysis identified for the first time a 274 
spontaneous amino-acid substitution in LLO (hlyG299V) and premature stop codons in hly 275 
(hlyN261* and hlyC484*) leading to the loss of LLO activity. Lower quantities of LLO were 276 
detected in the culture supernatants of the EGDΔhly:pPL2-hlyG299V and 277 
EGDΔhly:pPL2-hlyC484* constructs than for the EGD and EGDΔhly:pPL2-hlyWT strains. The 278 
quantity of hly transcripts was similar in the EGDΔhly:pPL2-hlyG299V and in the 279 
EGDΔhly:pPL2-hlyWT control, indicating that LLOG299V is likely less stable than WT LLO. In 280 
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contrast, EGDΔhly:pPL2-hlyC484* showed a lower hly transcription level, suggesting an 281 
impaired stability of hlyC484* transcript, relative to that of WT hly. In vivo experiments 282 
confirmed that the non-hemolytic strains harboring the hlyG299V or hlyC484* mutations have 283 
strongly attenuated virulence in mice. In line with these results, only three non-hemolytic 284 
strains were isolated from human samples. Although we did not have access to the detailed 285 
clinical data of these patients (dating back from the 1980s and 90s), one possibility would be 286 
that they were heavily immunocompromised, mirroring previous reports on isolation of the 287 
non-pathogenic Lm relative Listeria innocua from immunosuppressed individuals (35). 288 
One of the LLO- strains (CLIP 1998/76801) underwent huge genomic rearrangements that 289 
likely caused the loss of hly and gshF, encoding a glutathione synthase reported as being 290 
required for PrfA activity (28). CLIP 1998/76801 is the only strain in our entire genome 291 
database (~ 4,100 entries) that lacks gshF. Interestingly, each copy of the transposable 292 
element that likely caused the genomic rearrangements observed in this strain carried putative 293 
cadmium resistance determinants that could be advantageous in environments in which 294 
virulence determinants are not needed. Similar transposable elements were detected in 295 
monophyletic groups of CC1 and CC59 strains, suggesting that it has been horizontally 296 
transmitted in the Lm population. 297 
The predominance of PrfA- mutants among the non-hemolytic strains could reflect the fact 298 
that prfA is a pleiotropic regulatory gene that controls the expression of a number of virulence 299 
determinants, the expression of which is known to entail a significant fitness cost in non-host 300 
conditions (24). Our results show that, at 22°C, the majority of PrfA- strains have similar 301 
fitness than EGDe, suggesting that the absence of PrfA activity does not impact Lm fitness in 302 
non-pathogenic conditions. Nevertheless, a reduced fitness was observed at 37°C (mammalian 303 
host temperature), comparatively to EGDe∆prfA. This result suggests that non-hemolytic 304 
strains are more adapted to a non-pathogenic lifestyle, independently of PrfA. Consistent with 305 
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this, most of the non-hemolytic Lm isolates were from non-clinical origins. The ratio of non-306 
synonymous and synonymous substitutions (dN/dS) estimated for prfA (dN/dS=0.08892) and 307 
hly (dN/dS=0.03674) using a dataset of 100 genomes representative of Lm phylogenetic 308 
diversity (14) confirmed that, similarly to Lm core genes (dN/dS=0.05353 in average, (21)), 309 
these genes are under purifying selection. Thus, any deleterious mutations affecting these 310 
genes tend to be eliminated from Lm population. The exceptionally low frequency of 311 
deleterious mutations in prfA and hly indicates that there is a strong necessity for Lm to retain 312 
its virulence capacity (36). Our results also suggest that, although exceptionally, once strains 313 
loss their virulence capacity (e.g. due to a prfA mutation), other virulence genes may become 314 
unneeded and prone to accumulate mutations, as observed in our PrfA-/LLO- and PrfA-/GshF- 315 
strains. Previous studies have already identified strains with multiple mutations occurring in 316 
several major virulence genes (20). Strains with virulence attenuating mutations are therefore 317 
prone to enter into an evolutionary path towards obligate saprophytism. The Lm 318 
phylogenomic clade comprises another pathogenic species, Listeria ivanovii, with a full 319 
complement of PrfA-regulated genes, as well as non-pathogenic species, some of which 320 
contain remnants thereof (e.g. Listeria seeligeri or L. innocua) (37, 38). While infrequent, 321 
spontaneous virulence-disabling mutations, as those described here, could have been key 322 
initial events in the emergence and evolution of the Lm-related non-pathogenic Listeria 323 
species. 324 
 325 
Materials and methods 326 
Bacterial strains and growth media 327 
The 60 non-hemolytic Lm isolates included in this study were identified among a collection of 328 
57,820 Lm strains collected between 1987 and 2008 by the French National Reference Centre 329 
for Listeria (NRCL) and World Health Organization Collaborating Centre for Listeria 330 
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(WHOCCL) in the context of the epidemiological surveillance of listeriosis. This global 331 
collection included isolates of food (n = 36,630), clinical (n = 5,980), environmental 332 
(n = 3,647), veterinary (n = 1,713) and unknown (n = 9,850) origins. Isolates were revived by 333 
plating them onto Columbia Agar and single colonies were grown on Columbia Agar slants. 334 
Lm strains were routinely grown in BHI at 37°C and Escherichia coli strains were grown at 335 
37°C in LB broth or agar plates. 336 
 337 
Phenotypic characterization of Listeria isolates 338 
Miniaturized enzymatic and sugar fermentation tests (API-Listeria identification 339 
microgallery, BioMérieux, France), in combination with the hemolytic activity assessment of 340 
strains, were used for phenotypic identification of Listeria species (39). Hemolytic activity 341 
was tested on Columbia horse blood agar-plates (BioMérieux, France). Lm CLIP 74910 and 342 
Listeria innocua CLIP 74915 were used as positive and negative controls of hemolysis, 343 
respectively. 344 
 345 
Genome sequencing and analyses 346 
Genomic DNA was extracted using the DNeasy Blood and Tissue extraction kit (Qiagen, 347 
Denmark) and used for whole genome sequencing on Illumina NextSeq 500 (2 x 150 bp) 348 
platform (Illumina, California, USA). Reads were trimmed with AlienTrimmer (Criscuolo & 349 
Brisse 2013) to eliminate adapter sequences and discard reads with Phred scores of ≤ 20. De 350 
novo assembly of Illumina reads was performed using SPAdes Genome Assembler 3.1 (40). 351 
The complete genome of the CLIP 1998/76801 strain was obtained by PacBio RS II 352 
sequencing (Pacific Biosciences, California, USA) using DNA purified with the Wizard 353 
genomic DNA purification kit (Promega, Wisconsin, USA). Genome annotation was 354 
performed using Prokka 1.11 (41). 355 
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PCR-serogroups (12, 42), MLST profiles (13) and cgMLST profiles (21) were deduced from 356 
genome assemblies using the BIGSdb-Lm platform (http://bigsdb.pasteur.fr/listeria; (21)). 357 
Genome assemblies were made publicly available in the BIGSdb-Lm platform (Table S1). 358 
 359 
Assessment of prfA and hly evolutionary trends 360 
prfA and hly sequences were extracted from 100 genomes that were selected to represent the 361 
species diversity based on MLST and PFGE typing (14) and aligned using Muscle 3.8 (43). 362 
This dataset included genomes from 13 food isolates, 45 human clinical isolates, 19 animal 363 
isolates, 1 environmental isolate and 22 isolates of unknown origin. They comprised 41 364 
genomes of lineage I, 53 of lineage II, 5 of lineage III, and 1 of lineage IV and represented 5 365 
singletons and 34 clonal complexes based on MLST. No non-hemolytic strain was included in 366 
this analysis. Alignments were used to estimate the non-synonymous and synonymous ratios 367 
(dN/dS) of prfA and hly using the codeml program, included in the PAML 4.4 package (44). 368 
 369 
Assessment of PrfA activity 370 
PrfA activity was assessed by measuring the activity of PrfA-regulated plcB and hpt gene 371 
products as previously described (45, 46). For PlcB, lecithinase tests were performed in egg-372 
yolk BHI, for Hpt, glucose-1-phosphate acidification tests were carried out in phenol red 373 
broth, in both cases with and without 0.5% w/v activated charcoal (Merck, New Jersey, 374 
USA). Medium supplementation with charcoal leads to the partial activation of PrfA, 375 
presumably due to sequestration of repressor substances from the culture medium. Three Lm 376 
genotypes from strain P14 were used as controls: (i) prfAWT characterized by an activable 377 
PrfA phenotype (lack of PlcB and Hpt activity in normal medium and strong activity in 378 
charcoal-supplemented medium), (ii) ∆prfA which remains negative for PlcB and Hpt activity 379 
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in the presence of charcoal; and (iii) constitutively activated prfA* with strong PlcB and Hpt 380 
activity independently of charcoal supplementation (24, 45, 47). 381 
 382 
RNA extractions  383 
Non-hemolytic strains and EGD∆hly:pPL2-hlyWT, EGD∆hly:pPL2, EGD∆hly:pPL2-hlyG299V 384 
and EGD∆hly:pPL2-hlyC484* constructs were cultured overnight on BHI agar at 37°C. One 385 
colony was used to inoculate 5 ml of BHI broth. After overnight growth at 37°C, 500µl of 386 
culture was added to 10ml of BHI broth and the whole exponential phase culture (at 37°C) 387 
was centrifuged at 5,000 g for 5 min. The pellet was suspended with 400 µl of resuspension 388 
buffer (10% glucose, 12.5 mM TRIS, 10 mM EDTA in nuclease-free water) and transferred 389 
to a lysing tube (containing 0.1 mm of ceramic breads, 500 µl of acid phenol and 60 µl of 390 
EDTA 0.5 M). The Precellys24 homogenizer (Bertin Instruments, France) was used at 391 
6,500 rpm, for 2 x 23 s (10 s break), and the resulting mixture was centrifuged at 14,000 g at 392 
4°C for 10 min. The upper aqueous phase was transferred into a tube containing 1 ml of 393 
Trizol and 100 µl of chloroform, mixed by inversions and centrifuged. The upper aqueous 394 
phase was transferred into a tube containing 200 µl of chloroform, mixed by inversions and 395 
centrifuged. The upper aqueous phase was transferred into a storage tube (containing 650 µl 396 
of isopropanol and 65 µl sodium acetate 3 M), mixed by inversions, precipitated 20 min 397 
at -20°C and centrifuged during 20 min. The supernatant was rinsed twice with ethanol 75%. 398 
The air-dried pellet was dissolved in 300 µl of nuclease-free water. RNA concentrations were 399 
measured with the DeNovix DS-11 Spectrophotometer (DeNovix, Delaware, USA) and 400 
diluted to obtain 500 ng of RNA in 12.5 µl of nuclease-free water. 401 
 402 
Quantification of hly and prfA transcripts by qRT-PCR 403 
 18 
For the qRT-PCRs, cDNAs were generated prior to qPCRs. DNase treatment was performed 404 
with the RNase-free DNase I (New England BioLabs, Massachusetts, USA) according to the 405 
instructions of the manufacturer (by adding 0.5 µl of RNAseOUT, 0.5 µl of DNAseI and 406 
1.5 µl of buffer 10x to the 12.5 µl of diluted RNAs; then 1.5 µl of EDTA 0.05 M). cDNAs 407 
were generated by reverse transcription using the M-MLV Reverse Transcriptase (Invitrogen, 408 
California, USA) and random hexamers for priming according to the instructions of the 409 
manufacturer (by adding 2 µl of dNTPs 10 mM, 2 µl of random primers 2.5 µM and 3.5 µl of 410 
nuclease-free water to the 16.5 µl of previously DNase treated sample; then 8 µl of First-411 
Strand buffer 5x, 4 µl of DTT 0.1 M and 2 µl of nuclease-free water; then 0.5 µl of M-MLV 412 
RT). 413 
All quantitative PCRs were prepared using SYBR® Green Real-Time PCR Master Mixes and 414 
StepOnePlus™ Real-Time PCR System (Applied Biosystemss, California, USA). Each 415 
primer pair was used in separated reactions using PCR mixtures containing 1 µl of each 416 
primer 9 µM (Table S2), 5 µl of Sybr mix, 1 µl of cDNA diluted at 1:5 and 3 µl of 417 
nuclease-free water. Real-time PCR reactions were carried out in MicroAmp™ Fast Optical 418 
96-Well Reaction Plates (Applied Biosystems, California, USA) using the following protocol: 419 
initial denaturation at 95°C for 10 min, then 40 cycles of denaturation at 95°C for 15 s and 420 
primer annealing/elongation at 60°C for 1 min. Each strain was tested at least three times 421 
using independent pre-cultures. gyrB was used as stable reference gene for normalization. 422 
Results are shown as fold change of target gene expression relative to EGDe or EGD 423 
(Relative Quantities, RQs), which were deduced from the cycle threshold values (CTs) using 424 
the 2-∆∆CT methodology. 425 
 426 
Fitness studies 427 
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The microbial growth of non-hemolytic strains, EGDe, EGD and EGDe∆prfA was monitored 428 
over time in BHI at 22°C and 37°C using absorbance measurements (OD600nm) through the 429 
Bioscreen C® system (Oy Growth Curves Ab Ltd, Helsinki, Finland). Bacteria were first 430 
cultured overnight on BHI agar at 22°C or 37°C and one colony was used to inoculate 5 ml of 431 
BHI broth. After overnight growth, the stationary phase cultures were diluted to reach an 432 
OD600nm of 0.1 and transferred into Bioscreen C® 96-well plates. OD600nm of non-inoculated 433 
wells (blanks) were subtracted from inoculated ones to delete the background noise. Each 434 
strain was tested three times. Mean OD600nm per strain were used to calculate area under the 435 
curves over time. For this, data were fitted to parametric models (Gompertz, modified 436 
Gompertz, Logistic and Richards laws) using the “gcFit” function of the “grofit” R package 437 
v.1.1.1-1 (48). The model that best fitted the data was selected by means of an AIC criterion 438 
(49) and used to derive areas under the growth curves. 439 
 440 
DNA manipulations and cloning 441 
We used a two-step cloning strategy to introduce the wild type hly (hlyWT), hlyG299V or hlyC484* 442 
in the Lm strain EGD∆hly. First, we cloned separately the hlyWT, hlyG299V and hlyC484* gene 443 
sequences into the Listeria integrative vector pPL2 (50). Primers used are listed in the Table 444 
S2. To deliver plasmids into Lm, Escherichia coli S17.1 (colistin and nalidixic acid sensitive) 445 
were transformed with the plasmids followed by conjugation with Lm EGDΔhly (colistin and 446 
nalidixic acid resistant). Lm EGDΔhly were selected on 7µg/ml chloramphenicol (bacteria 447 
containing the pPL2 derivatives), 10µg/ml colicin and 50µg/ml nalidixic acid (selection of 448 
resistant Lm vs sensitive E. coli). Since all our constructs were made on a similar EGD 449 
background, no impact of the PrfA* phenotype of EGD is expected on our results and 450 
conclusions. 451 
 452 
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Western blotting 453 
Protein extracts were obtained from EGD, EGDΔhly, EGDΔhly:pPL2, EGDΔhly:pPL2-hlyWT, 454 
EGDΔhly:pPL2-hlyG299V and EGDΔhly:pPL2-hlyC484* as follows. Bacteria were grown 455 
overnight in BHI broth at 37°C. After centrifugation of bacterial cultures (30 min; 2,151 g), 456 
all proteins of the supernatant were precipitated by using trichloroacetic acid (20%) and 457 
washed using acetone. Proteins were then separated by SDS/PAGE (8% acrylamide gel and 458 
3.9% stacking gel) and transferred to a polyvinylidene difluoride transfer membrane (Bio-459 
Rad, California, USA). The membrane was incubated overnight at 4°C with a blocking buffer 460 
containing dried milk (5%), phosphate buffered saline (PBS, 1%) and Tween (0.1%) and 461 
washed with PBS (1%) and Tween (0.1%). It was then incubated first with a polyclonal anti-462 
LLO (51, 52) or anti-InlC antibody (53) (1/20,000; 1h; room temperature) and second with 463 
the anti-rabbit antibody (1/3,000; 1h; room temperature). The membrane was washed with 464 
PBS (1%) and Tween (0.1%) between each incubation step with antibodies. Antibody-antigen 465 
interactions were revealed using a SuperSignal West Pico Chemiluminescent substrate 466 
(Thermo Fischer Scientific, Massachussetts, USA). 467 
 468 
Animal studies 469 
The virulence of Lm strains EGDΔhly:pPL2-hlyWT, EGDΔhly:pPL2-hlyG299V, 470 
EGDΔhly:pPL2-hlyC484* and EGDΔhly:pPL2 was assessed in vivo. Balb/c mice were infected 471 
via intravenous route with 1.104 colony-forming units (CFUs) per animal. At 72 h post 472 
infection, mice were sacrificed for spleen and liver dissection. CFUs were enumerated by 473 
plating dilutions of the whole homogenized organs onto BHI plates. Statistical analyses were 474 
done using the Mann–Whitney U test as compared with EGD∆hly:pPL2-hlyWT. 475 
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 660 
Figure legends 661 
Figure 1: Phylogenetic tree summarizing all the genetic features causing the loss of 662 
hemolytic activity among the 60 non-hemolytic Lm strains. 663 
Single-linkage based clustering was obtained based on the cgMLST allelic profiles, as 664 
described previously (21). Scale bar indicates % of cgMLST similarity. Strain names have 665 
been simplified to avoid redundancy and should be preceded by “CLIP”. PrfA activities and 666 
mutations (first and second columns, respectively), gshF presence/absence profile (third 667 
column) and LLO mutations and presence/absence profile (fourth column) are mapped on the 668 
phylogeny. Position and nature of amino acid substitutions are indicated in grey zones. 669 
Positions of premature stop codons are indicated next to black asterisks in light pink zones. 670 
Absence of gshF and hly in the CLIP 1998/76801 strain is indicated in black. MLST clonal 671 
complexes are shown on the right. The black star highlights the CLIP 1998/76801 strain that 672 
contains multiple copies of a transposable element that induced huge genomic 673 
rearrangements. ND: unknown and non-human origin. 674 
 675 
Figure 2: Comparison of the CLIP 1998/76801 and F2365 genomes 676 
A. Gene content of the LIPI-1 region in F2365 (accession number: NC_002973) (top) in 677 
comparison to the corresponding region in the non-hemolytic CLIP 1998/76801 strain 678 
(bottom). LIPI-1 genes are highlighted in red. mpl is composed of 1532 bp in F2365 against 679 
1133 bp in CLIP 1998/76801. B. Gene content of the gshF region in F2365 (top) in 680 
comparison to the corresponding region in CLIP 1998/76801 (bottom). In A. and B., genes 681 
that are present in CLIP 1998/76801 but absent in F2365 are indicated in orange. Genes 682 
encoding the transposition protein (tnsB), the DNA-invertase (hin) and the cadmium 683 
resistance genes (cadA and cadC) are indicated. C. Global comparison of the F2365 (top) and 684 
 31 
the CLIP 1998/76801 (bottom) genomes. Positions of the eight copies of the transposable 685 
element are indicated in dark blue. Identity percentages (indicated by grey zones of variable 686 
intensities) between sequences were determined by nucleotide BLAST (54). Genome 687 
comparisons were performed using Easyfig 2.1 (55). 688 
 689 
Figure 3: Characterization of the G299V substitution in LLO and the truncated LLO at 690 
positon 484. 691 
A. Western blotting of the culture supernatants of EGD and EGD∆hly complemented or not 692 
with the pPL2 plasmid alone or containing hlyWT, hlyG299V or hlyC484*. LLO detection was 693 
performed by using LLO-specific antibodies (above) and InlC-specific antibodies were used 694 
as loading controls (below). B. qRT-PCR quantification of hly transcripts produced in BHI at 695 
37°C by the EGD∆hly strain complemented with the pPL2 plasmid alone or containing the 696 
hlyWT, hlyG299V or hlyC484* genes. Each strain was tested at least three times using independent 697 
pre-cultures. gyrB was used as stable reference gene for normalization. Results are shown as 698 
fold change of hly expression relative to EGD (Relative Quantities, RQs). Each central bar 699 
represents the mean of at least three replications. Error bars indicate standard deviations from 700 
the means. C. In vivo characterization of the hlyG299V and hlyC484* mutations as compared to 701 
the hlyWT. Each Balb/C mice were infected intravenously with 1.104 CFUs. Animals were 702 
sacrificed 72 h after infection. Numbers of CFUs per organ are shown for all the tested 703 
strains. No bacteria could be recovered from the liver of mice infected by 704 
EGD∆hly:pPL2-hlyG299V and EGD∆hly:pPL2 strains; and from the spleen of mice infected by 705 
EGD∆hly:pPL2. Statistical analyses were done by a Mann-Whitney U test as compared with 706 
EGD∆hly:pPL2-hlyWT. 707 



